| Phase 2a Evaluation of Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Patients With Primary Sclerosing Cholangitis (PSC) (NCT04480840) | Pliant Therapeutics, Inc. | 2020-07-27 |
| A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) (NCT04449029) | GlaxoSmithKline | 2020-07-27 |
| A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. (NCT04494984) | Inmunova S.A. | 2020-07-27 |
| Study of Combination Therapy With INCMGA00012 (Anti-PD-1), INCAGN02385 (Anti-LAG-3), and INCAGN02390 (Anti-TIM-3) in Participants With Select Advanced Malignancies (NCT04370704) | Incyte Corporation | 2020-07-27 |
| WIRE - Novel Treatments in Renal Cell Cancer (NCT03741426) | CCTU- Cancer Theme | 2020-07-27 |
| Efficacy of VIC Regimen in BRAF Mutant Metastatic Colorectal Cancer (NCT04790448) | Sun Yat-sen University | 2020-07-27 |
| Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL (NCT04499573) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-07-27 |
| Metformin in Dengue With Obesity (NCT04377451) | Oxford University Clinical Research Unit, Vietnam | 2020-07-27 |
| Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial (NCT04486911) | Shengjing Hospital | 2020-07-27 |
| IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer (NCT05551507) | InxMed (Shanghai) Co., Ltd. | 2020-07-27 |
| Zanubrutinib-rituximab(ZR) in Patients With Newly Diagnosed Untreated Mantle Cell Lymphoma (NCT05504603) | The First Affiliated Hospital of Soochow University | 2020-07-27 |
| A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State (NCT04451772) | AbbVie | 2020-07-27 |
| Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With Presbyopia (NCT04403763) | AbbVie | 2020-07-27 |
| Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19 (NCT04527575) | Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" | 2020-07-27 |
| PoC Study to Evaluate the Efficacy and Safety of Secukinumab 300 mg in Patients With Lichen Planus (NCT04300296) | Novartis Pharmaceuticals | 2020-07-27 |
| Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma (NCT04432506) | M.D. Anderson Cancer Center | 2020-07-27 |
| Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor (NCT05455918) | Yonsei University | 2020-07-26 |
| Neoadjuvant Afatinib Therapy for Potentially Resectable Stage III EGFR Mutation-Positive Lung Adenocarcinoma (NCT04201756) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-07-26 |
| Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer (NCT04379739) | Shanghai Pulmonary Hospital, Shanghai, China | 2020-07-26 |
| DAS181 for STOP COVID-19 (NCT04354389) | Ansun Biopharma, Inc. | 2020-07-25 |
| Topical Cetirizine in Androgenetic Alopecia in Females (NCT04481412) | Cairo University | 2020-07-25 |
| Comparative Study Evaluating the Effect of Vitamin K1 Versus Vitamin K2 on Vascular Calcification in Dialysis Patients (NCT04477811) | Ain Shams University | 2020-07-25 |
| Desidustat in the Management of COVID-19 Patients (NCT04463602) | Zydus Lifesciences Limited | 2020-07-25 |
| Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19 (NCT04493359) | University of Sao Paulo | 2020-07-25 |
| Tyrosine Kinase Inhibitor (TKI) + Anti-PD-1 Antibody in TKI-responded Microsatellite Stability/Proficient Mismatch Repair (MSS/pMMR) Metastatic Colorectal Adenocarcinoma. (NCT04483219) | China Medical University, China | 2020-07-24 |
| Evaluation of the Efficacy and Safety of VX-864 in Subjects With the PiZZ Genotype (NCT04474197) | Vertex Pharmaceuticals Incorporated | 2020-07-24 |
| A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP (NCT04428255) | Harbour BioMed (Guangzhou) Co. Ltd. | 2020-07-24 |
| Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder (NCT04576286) | Ain Shams University | 2020-07-24 |
| Nitric Oxide Therapy for COVID-19 Patients With Oxygen Requirement (NCT04476992) | Tomsk National Research Medical Center of the Russian Academy of Sciences | 2020-07-24 |
| KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC (NCT04265534) | Calithera Biosciences, Inc | 2020-07-24 |
| A Phase Ⅱ Clinical Study of Sanhuangjingshimingwan in Wet( Neovascular)Age-related Macular Degeneration(wAMD) Subjects (NCT04486963) | Tasly Pharmaceutical Group Co., Ltd | 2020-07-24 |
| Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS (NCT04449588) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2020-07-23 |
| Niraparib + Dostarlimab + RT in Pancreatic Cancer (NCT04409002) | Massachusetts General Hospital | 2020-07-23 |
| TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study (NCT03920254) | Theravance Biopharma | 2020-07-23 |
| A Study to Evaluate the Efficacy, Safety and PD and PK of HBM9161 in MG Patients (NCT04346888) | Harbour BioMed (Guangzhou) Co. Ltd. | 2020-07-23 |
| Low Dose Whole Lung Radiation Therapy for Patients With COVID-19 and Respiratory Compromise (NCT04427566) | Ohio State University | 2020-07-23 |
| A Novel Therapeutic Vaccine (EO2401) in Metastatic Adrenocortical Carcinoma, or Malignant Pheochromocytoma/Paraganglioma (NCT04187404) | Enterome | 2020-07-23 |
| Targeting EGFR/ERBB2 With Neratinib in Hormone Receptor (HR)-Positive/HER2-negative HER2-enriched Advanced/Metastatic Breast Cancer (NCT04460430) | SOLTI Breast Cancer Research Group | 2020-07-23 |
| Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL (NCT04476459) | Huiqiang Huang | 2020-07-23 |
| Neo-Adjuvant Abemaciclib With Fulvestrant in Patients With ER/PR +HER Negative Breast Cancer (NCT04305236) | University of California, Irvine | 2020-07-23 |
| Favipiravir Therapy in Adults With Mild COVID-19 (NCT04464408) | King Abdullah International Medical Research Center | 2020-07-23 |
| A Pilot Study of the Efficacy and Safety of Dupilumab Versus Placebo in Patients With Netherton Syndrome (NCT04244006) | University Hospital, Toulouse | 2020-07-23 |
| Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection (NCT04447235) | Instituto do Cancer do Estado de São Paulo | 2020-07-23 |
| Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction (NCT04479917) | Vigonvita Life Sciences | 2020-07-23 |
| Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas (NCT04331119) | Washington University School of Medicine | 2020-07-23 |
| BuqitongluO Granule for Qi Deficiency and Blood Stasis Syndrome (NCT04408261) | Dongzhimen Hospital, Beijing | 2020-07-22 |
| TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children (NCT04414046) | Johns Hopkins All Children's Hospital | 2020-07-22 |
| A Study of NGM621 in Participants With Geographic Atrophy (NCT04465955) | NGM Biopharmaceuticals, Inc | 2020-07-22 |
| Study of RP-3500, Camonsertib, in Advanced Solid Tumors (NCT04497116) | Repare Therapeutics | 2020-07-22 |
| Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite (NCT04401527) | Hope Pharmaceuticals | 2020-07-22 |
| A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors (NCT04420884) | Takeda | 2020-07-22 |
| A Phase I/IIa Clinical Trial to Assess Feasibility, Safety and Antitumor Activity of Autologous SLAMF7 CAR-T Cells in Multiple Myeloma (NCT04499339) | Wuerzburg University Hospital | 2020-07-22 |
| Administration of Ropivacaine by Bi-laterosternal Multiperforated Catheters Placed Before a Sternotomy for Cardiac Surgery (NCT04495504) | University Hospital, Clermont-Ferrand | 2020-07-22 |
| MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients (NCT04032626) | St. Joseph's Hospital and Medical Center, Phoenix | 2020-07-22 |
| Olfactory and Neurosensory Rehabilitation in COVID-19-related Olfactory Dysfunction (NCT04900415) | Ivan FN Hung MD | 2020-07-22 |
| Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma (NCT04203901) | CoImmune | 2020-07-22 |
| A Study to Evaluate the Safety, Tolerability and Efficacy of Cabozantinib in Patients With Hepatocellular Carcinoma and Impaired Liver Function (NCT04454762) | Johannes Gutenberg University Mainz | 2020-07-22 |
| Atovaquone for Treatment of COVID-19 (NCT04456153) | University of Texas Southwestern Medical Center | 2020-07-22 |
| TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children (NCT04356469) | Johns Hopkins All Children's Hospital | 2020-07-22 |
| Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations (NCT04493138) | M.D. Anderson Cancer Center | 2020-07-21 |
| Safety and Efficacy of C21 in Subjects With COVID-19 (NCT04452435) | Vicore Pharma AB | 2020-07-21 |
| Deferoxamine for Sickle Cell Chronic Leg Ulcer Treatment (NCT04058197) | TauTona Group | 2020-07-21 |
| Study of Remdesivir in Participants Below 18 Years Old With COVID-19 (NCT04431453) | Gilead Sciences | 2020-07-21 |
| Clinical Performance of a One-step Self-etch Adhesive in Non-carious Cervical Lesions at 2 Years (NCT04565938) | University of Athens | 2020-07-21 |
| Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD) (NCT04893941) | Keymed Biosciences Co.Ltd | 2020-07-21 |
| Azacitidine, Venetoclax, and Trametinib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndrome (NCT04487106) | M.D. Anderson Cancer Center | 2020-07-21 |
| Pembrolizumab + Paclitaxel in HR+/HER2- Non-luminal (by PAM50) Advanced Breast Cancer After CDK4/6 Inhibitor Progression (NCT04251169) | SOLTI Breast Cancer Research Group | 2020-07-21 |
| Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer (NCT04390399) | ImmunityBio, Inc. | 2020-07-21 |
| A Study of TQ-B3525 Tablet in the Treatment of Relapsed / Refractory Mantle Cell Lymphoma (MCL) (NCT04398953) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-07-20 |
| A Trial of Aclaris Therapeutics, Inc. (ATI)-450 in Patients With Moderate-severe Novel Coronavirus Disease 2019 (COVID-19) (NCT04481685) | University of Kansas Medical Center | 2020-07-20 |
| Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC (NCT04468061) | Dana-Farber Cancer Institute | 2020-07-20 |
| Ivosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial) (NCT04195555) | National Cancer Institute (NCI) | 2020-07-20 |
| Evaluation of Safety and Efficiency of Method of Exosome Inhalation in SARS-CoV-2 Associated Pneumonia. (NCT04491240) | State-Financed Health Facility "Samara Regional Medical Center Dinasty" | 2020-07-20 |
| Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA (NCT04097379) | Novartis Pharmaceuticals | 2020-07-20 |
| Safety and Efficacy Study of VIS649 for IgA Nephropathy (NCT04287985) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2020-07-20 |
| Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker (NCT04334941) | National Cancer Institute (NCI) | 2020-07-20 |
| A Study on the Anti-Wrinkle Efficacy Assessment and Safety Evaluation of the Cluster of Autologous Dermal Fibroblast on Bilateral Crow's Feet (NCT04818203) | S.Biomedics Co., Ltd. | 2020-07-20 |
| A Study of AL2846 Capsule Combined With Standard Chemotherapy Regimen in Subjects With Advanced Colorectal Cancer (NCT04337879) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-07-20 |
| MEN1611 With Cetuximab in Metastatic Colorectal Cancer (C-PRECISE-01) (NCT04495621) | Menarini Group | 2020-07-20 |
| OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis (NCT04375878) | Entero Therapeutics | 2020-07-20 |
| Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer (NCT04443062) | Radboud University Medical Center | 2020-07-20 |
| Aprepitant Injectable Emulsion in Patients With COVID-19 (GUARDS-1) (NCT04470622) | Heron Therapeutics | 2020-07-20 |
| Study of the Impact of DPD Activity on the Efficacy of Capecitabine (NCT04198727) | Centre Antoine Lacassagne | 2020-07-20 |
| Vitamin C as add-on Therapy in Patients With Acute Herpes Zoster (NCT05561257) | Pascoe Pharmazeutische Praeparate GmbH | 2020-07-20 |
| Evaluation of PET Probe [68Ga]CBP8 in the Detection of Radiation Induced Tissue Injury (NCT04485286) | Massachusetts General Hospital | 2020-07-19 |
| Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas (NCT04074746) | M.D. Anderson Cancer Center | 2020-07-18 |
| Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents (NCT04472143) | Fudan University | 2020-07-18 |
| A Phase II Study of Subcutaneously Injected PD-L1 Antibody ASC22 in Chronic Hepatitis B Patients (NCT04465890) | Ascletis Pharmaceuticals Co., Ltd. | 2020-07-17 |
| 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression (NCT04235686) | Mayo Clinic | 2020-07-17 |
| Evaluation of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD) (NCT04391959) | Azura Ophthalmics | 2020-07-17 |
| Clinical Trial to Evaluate CERC-002 in Adults With COVID-19 Pneumonia and Acute Lung Injury (NCT04412057) | Aevi Genomic Medicine, LLC, a Cerecor company | 2020-07-17 |
| Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN (NCT04317105) | National Cancer Institute (NCI) | 2020-07-17 |
| Quizartinib and High-dose Ara-C Plus Mitoxantrone in Relapsed/Refractory AML With FLT3-ITD (NCT03989713) | Prof. Dr. Richard F Schlenk | 2020-07-17 |
| Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies (NCT04561362) | BicycleTx Limited | 2020-07-17 |
| A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis (NCT04444752) | Connect Biopharm LLC | 2020-07-17 |
| SNIFF Multi-Device Study 2 (NCT04199767) | Wake Forest University Health Sciences | 2020-07-16 |
| Acalabrutinib, Lenalidomide, and Rituximab for the Treatment of CD20 Positive Stage III-IV, Grade 1-3a Follicular Lymphoma (NCT04404088) | M.D. Anderson Cancer Center | 2020-07-16 |
| Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases (NCT03965234) | Roswell Park Cancer Institute | 2020-07-16 |
| Immune Checkpoint Inhibitor In High Risk Oral Premalignant Lesions (NCT04504552) | Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 2020-07-16 |
| Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation (NCT04233021) | Intergroupe Francophone de Cancerologie Thoracique | 2020-07-16 |